ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

17 links0 made here, not in the record17 judgments1 judge (the rules as one: Rule based)15 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06124157A Study Testing theCombination of Dasatinib orImatinib to ChemotherapyTreatment With Blinatumomabfor Children, Adolescents,and Young Adults WithPhiladelphia ChromosomeNational Cancer Institute (NCIPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 25 · ClinicalTrials.gov record · Version of 2026-09-25Sep 28 · ClinicalTrials.gov record · Version of 2026-09-28Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 8 · ClinicalTrials.gov record · Version of 2026-10-08Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Oct 15 · ClinicalTrials.gov record · Version of 2026-10-15Oct 19 · ClinicalTrials.gov record · Version of 2026-10-19Oct 20 · ClinicalTrials.gov record · Version of 2026-10-20Oct 21 · ClinicalTrials.gov record · Version of 2026-10-21Oct 23 · ClinicalTrials.gov record · Version of 2026-10-23Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Oct 27 · ClinicalTrials.gov record · Version of 2026-10-27Version of 2026-10-27CONDITIONSBurkitt LymphomaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSBlinatumomabIntervention entry›As of now · Rule based · BackgroundBackgroundCalaspargase pegolIntervention entry›As of now · Rule based · BackgroundBackgroundCyclophosphamideIntervention entry›As of now · Rule based · BackgroundBackgroundCytarabineIntervention entry›As of now · Rule based · BackgroundBackgroundDasatinibIntervention entry›As of now · Rule based · TestedTestedDaunorubicinIntervention entry›As of now · Rule based · BackgroundBackgroundDoxorubicinIntervention entry›As of now · Rule based · BackgroundBackgroundImatinibIntervention entry›As of now · Rule based · TestedTestedLeucovorinIntervention entry›As of now · Rule based · BackgroundBackgroundMercaptopurineIntervention entry›As of now · Rule based · BackgroundBackgroundMethotrexateIntervention entry›As of now · Rule based · BackgroundBackgroundPegaspargaseIntervention entry›As of now · Rule based · BackgroundBackgroundPrednisoloneIntervention entry›As of now · Rule based · BackgroundBackgroundPrednisoneIntervention entry›As of now · Rule based · BackgroundBackgroundThioguanineIntervention entry›As of now · Rule based · BackgroundBackgroundVincristineIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Burkitt Lymphoma

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryBurkitt Lymphoma, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Sep 25The record itselfClinicalTrials.gov recordVersion of 2026-09-25Record change
Sep 28The record itselfClinicalTrials.gov recordVersion of 2026-09-28Record change
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 2The record itselfClinicalTrials.gov recordVersion of 2026-10-02Record change
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 8The record itselfClinicalTrials.gov recordVersion of 2026-10-08Record change
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Oct 15The record itselfClinicalTrials.gov recordVersion of 2026-10-15Record change
Oct 19The record itselfClinicalTrials.gov recordVersion of 2026-10-19Record change
Oct 20The record itselfClinicalTrials.gov recordVersion of 2026-10-20Record change
Oct 21The record itselfClinicalTrials.gov recordVersion of 2026-10-21Record change
Oct 23The record itselfClinicalTrials.gov recordVersion of 2026-10-23Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Oct 27The record itselfClinicalTrials.gov recordVersion of 2026-10-27Record change
As of nowBurkitt LymphomaRule based · main-condition ruleMain conditionCurrent
As of nowBlinatumomabRule based · role ruleBackgroundCurrent
As of nowCalaspargase pegolRule based · role ruleBackgroundCurrent
As of nowCyclophosphamideRule based · role ruleBackgroundCurrent
As of nowCytarabineRule based · role ruleBackgroundCurrent
As of nowDasatinibRule based · role ruleTestedCurrent
As of nowDaunorubicinRule based · role ruleBackgroundCurrent
As of nowDoxorubicinRule based · role ruleBackgroundCurrent
As of nowImatinibRule based · role ruleTestedCurrent
As of nowLeucovorinRule based · role ruleBackgroundCurrent
As of nowMercaptopurineRule based · role ruleBackgroundCurrent
As of nowMethotrexateRule based · role ruleBackgroundCurrent
As of nowPegaspargaseRule based · role ruleBackgroundCurrent
As of nowPrednisoloneRule based · role ruleBackgroundCurrent
As of nowPrednisoneRule based · role ruleBackgroundCurrent
As of nowThioguanineRule based · role ruleBackgroundCurrent
As of nowVincristineRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.